The Duchenne Muscular Dystrophy Market: What’s Next After Exon-Skipping Therapies?
The Duchenne Muscular Dystrophy Market: What’s Next After Exon-Skipping Therapies?
Duchenne Muscular Dystrophy Market: What’s More Beyond Exon-Skipping Therapies?
Duchenne Muscular Dystrophy (DMD) is a severe genetic disorder characterized by progressive muscle degeneration and weakness. While exon-skipping therapies have been at the forefront of recent advancements, the...